Journal
NATURE CELL BIOLOGY
Volume 12, Issue 8, Pages 758-U26Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb2080
Keywords
-
Categories
Funding
- Agency for Science Technology and Research, Singapore (AstarStar)
- Leducq Foundation
- Meriaux Foundation
- Ellison Medical Foundation
- Ipsen/Biomeasure
- Sanofi Aventis
- H.N. and Frances C. Berger Foundation
Ask authors/readers for more resources
We describe a genome-wide gain-of-function screen for regulators of NF-kappa B, and identify Rap1 (Trf2IP), as an essential modulator of NF-kappa B-mediated pathways. NF-kappa B is induced by ectopic expression of Rap1, whereas its activity is inhibited by Rap1 depletion. In addition to localizing on telomeres, mammalian Rap1 forms a complex with IKKs (I kappa B kinases), and is crucial for the ability of IKKs to be recruited to, and phosphorylate, the p65 subunit of NF-kappa B to make it transcriptionally competent. Rap1-mutant mice display defective NF-kappa B activation and are resistant to endotoxic shock. Furthermore, levels of Rap1 are positively regulated by NF-kappa B, and human breast cancers with NF-kappa B hyperactivity show elevated levels of cytoplasmic Rap1. Similar to inhibiting NF-kappa B, knockdown of Rap1 sensitizes breast cancer cells to apoptosis. These results identify the first cytoplasmic role of Rap1 and provide a mechanism through which it regulates an important signalling cascade in mammals, independent of its ability to regulate telomere function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available